An evaluation of CZ4D inhalation powder in a single ascending dose in healthy subjects (Part 1), multiple ascending doses in patients with mild stable asthma (Part 2), and a two-cycle, crossover design in patients with mild to moderate stable asthma (Part III) Phase I clinical study of safety, tolerability and pharmacokinetic characteristics